[Federal Register Volume 63, Number 173 (Tuesday, September 8, 1998)]
[Notices]
[Page 47504]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-24003]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Anti-Infective Drugs Advisory Committee; Notice of Meeting

AGENCY:  Food and Drug Administration, HHS.

ACTION:  Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). The meeting will 
be open to the public.
    Name of Committee: Anti-Infective Drugs Advisory Committee.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on October 15 and 16, 1998, 
8 a.m. to 5 p.m.
    Location: Holiday Inn--Silver Spring, Kennedy Grand Ballroom, 8777 
Georgia Ave., Silver Spring, MD.
    Contact Person: Ermona B. McGoodwin, Center for Drug Evaluation and 
Research (HFD-21), Food and Drug Administration, 5600 Fishers Lane, 
Rockville, MD 20857, 301-827-7001, or FDA Advisory Committee 
Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC 
area), code 12530. Please call the Information Line for up-to-date 
information on this meeting.
    Agenda: The committee will discuss the development of drug products 
for resistant bacteria, including selective spectrum agents.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person by October 9, 
1998. Oral presentations from the public will be scheduled between 
approximately 1 p.m. and 1:30 p.m. Time allotted for each presentation 
may be limited. Those desiring to make formal presentations should 
notify the contact person before October 9, 1998, and submit a brief 
statement of the general nature of the evidence or arguments they wish 
to present, the names and addresses of proposed participants, and an 
indication of the approximate time requested to make their 
presentation.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: September 1, 1998.
Michael A. Friedman,
Deputy Commissioner for Operations.
[FR Doc. 98-24003 Filed 9-4-98; 8:45 am]
BILLING CODE 4160-01-F